Watach, I hope you are right...but they are doing a shiiity job getting the message to any big money investors. A really lousy job, and that is their full time job, there is only so much time the executive time can spend working on the development side in this stage.
They need to focus on getting funds to invest for all this theoretical upside you point out. It sounds simple, but that is what it boils down to. They have some cash in the bank, and they seemingly have just forgotten how to market the value of this company. If they are waiting on FDA approval...they are #$%$ nuts. Need to always be marketing to investors...and successfully so.
I want to think..well, it's the market. But no...this just has no support. I know they took 10M in funding...that seemed to be promising but I guess Novartis just wasted its money as well. No pick up from the recent conferences. Just nothing going on. Disgusted feelings from a long time investor.